Controlling the burden of metastatic disease in pancreatic ductal adenocarcinoma

Ended Project Grant Awarded Last action

Award ID
W81XWH2210730
Recipient
Awarding agency
Obligated
$296,595

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Philadelphia, PA 19104, USA

Award details come from USAspending.gov.

About this award

The Trustees of the University of Pennsylvania received a $296,595 Project Grant award from the Department of the Army Medical Command on September 15, 2022 to complete work by September 14, 2025. The grant supports the "Controlling the Burden of Metastatic Disease in Pancreatic Ductal Adenocarcinoma" project conducted in Philadelphia, PA under the Military Medical Research and Development program (CFDA 12.420).

This program aims to transform military and public health through innovative medical research solutions. The University of Pennsylvania will work to investigate controlling metastatic disease in pancreatic cancer, advancing the program's goal of developing medical solutions for service members and the public. The three-year period of performance will allow for applied research toward controlling this difficult-to-treat form of cancer.

Quick answers

Who received award W81XWH2210730?

W81XWH2210730 was awarded to The Trustees Of The University Of Pennsylvania by Medical Command (Department of the Army) on September 15, 2022.

How much is award W81XWH2210730 worth?

$296,595 has been obligated on W81XWH2210730.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award